Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature

References

• National Institute for Health and Care ExcellenceSpondyloarthritis in Over 16s: Diagnosis and ManagementLondonNICE2017
   Google Scholar
• RaychaudhuriSPRaychaudhuriSKMechanistic rationales for targeting interleukin-17A in spondyloarthritisArthritis Res Ther20171915128270233
   PubMed Web of Science ®Google Scholar
• WendlingDTreating to target in axial spondyloarthritis: defining the target and the arrowExpert Rev Clin Immunol201511669169325905676
   PubMed Web of Science ®Google Scholar
• StolwijkCBoonenAvan TubergenAReveilleJDEpidemiology of spondyloarthritisRheum Dis Clin North Am201238344147623083748
   PubMed Web of Science ®Google Scholar
• GladmanDDAntoniCMeasePCleggDONashPPsoriatic arthritis: epidemiology, clinical features, course, and outcomeAnn Rheum Dis200564Suppl 2ii14ii1715708927
   PubMed Web of Science ®Google Scholar
• LiuJTYehHMLiuSYChenKTPsoriatic arthritis: epidemiology, diagnosis, and treatmentWorld J Orthop20145453754325232529
   PubMedGoogle Scholar
• SinghJAStrandVSpondyloarthritis is associated with poor function and physical health-related quality of lifeJ Rheumatol20093651012102019369461
   PubMed Web of Science ®Google Scholar
• LozaEJoverJARodriguezLCarmonaLMultimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic diseaseSemin Arthritis Rheum200938431231918336872
   PubMed Web of Science ®Google Scholar
• al MainiMAdelowoFal SalehJThe global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal DiseasesClin Rheumatol201534581982925501633
   PubMed Web of Science ®Google Scholar
• el MaghraouiAExtra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implicationsEur J Intern Med201122655456022075279
   PubMed Web of Science ®Google Scholar
• SmolenJSLandewéRBreedveldFCEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnn Rheum Dis201473349250924161836
   PubMed Web of Science ®Google Scholar
• BraunJvan den BergRBaraliakosX2010 Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisAnn Rheum Dis201170689690421540199
   PubMed Web of Science ®Google Scholar
• GossecLSmolenJSGaujoux-VialaCEuropean League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapiesAnn Rheum Dis201271141221953336
   PubMed Web of Science ®Google Scholar
• SchoelsMKnevelRAletahaDEvidence for treating rheumatoid arthritis to target: results of a systematic literature searchAnn Rheum Dis201069463864320237123
   PubMed Web of Science ®Google Scholar
• KavanaughACohenSCushJJThe evolving use of tumor necrosis factor inhibitors in rheumatoid arthritisJ Rheumatol200431101881188415468347
   PubMed Web of Science ®Google Scholar
• HillJAdherence with drug therapy in the rheumatic diseases – part one: a review of adherence ratesMusculoskeletal Care200532617317041995
   PubMedGoogle Scholar
• BartonJLPatient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapyPatient Prefer Adherence2009333534420016797
   PubMed Web of Science ®Google Scholar
• HigginsJPGreenSCochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0LondonCochrane Collaboration2011
   Google Scholar
• Centre for Evidence-Based Medicine [homepage on the Internet] Available from: https://www.cebm.netAccessed March 26, 2018
   Google Scholar
• SalaffiFCarottiMGaspariniSIntorciaMGrassiWThe health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy peopleHealth Qual Life Outcomes200972519296831
   PubMed Web of Science ®Google Scholar
• JajićZRajnprehtIKovačićNWhich clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?Rheumatol Int201232113471347922065069
   PubMed Web of Science ®Google Scholar
• KotsisKVoulgariPVTsifetakiNAnxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of lifeArthritis Care Res (Hoboken)201264101593160122556134
   PubMed Web of Science ®Google Scholar
• HyphantisTKotsisKTsifetakiNThe relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritisClin Rheumatol201332563564423329349
   PubMed Web of Science ®Google Scholar
• ChorusAMMiedemaHSBoonenAvan der LindenSQuality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working ageAnn Rheum Dis200362121178118414644855
   PubMed Web of Science ®Google Scholar
• KawalecPMalinowskiKPPilcADisease activity, quality of life and indirect costs of psoriatic arthritis in PolandRheumatol Int20163691223123027339273
   PubMed Web of Science ®Google Scholar
• HromadkovaLSoukupTVlcekJQuality of life and drug compliance: their interrelationship in rheumatic patientsJ Eval Clin Pract201521591992426083391
   PubMed Web of Science ®Google Scholar
• SaadAAAshcroftDMWatsonKDImprovements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapiesArthritis Care Res (Hoboken)201062334535320391480
   PubMed Web of Science ®Google Scholar
• SieperJHolbrookTBlackCMWoodRHuXKachrooSBurden of illness associated with non-radiographic axial spondyloarthritis: a multiperspective European cross-sectional observational studyClin Exp Rheumatol201634697598327749215
   PubMed Web of Science ®Google Scholar
• WallmanJKKapetanovicMCPeterssonIFGeborekPKristensenLEComparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients: baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practiceArthritis Res Ther201517137826703005
   PubMed Web of Science ®Google Scholar
• KucharzEJKotulskaAKopeć-MędrekMWiduchowskaMOpinion of patients with ankylosing spondylitis on risk factors impairing their quality of lifeRheumatol Int201333112899290122983136
   PubMed Web of Science ®Google Scholar
• Ariza-ArizaRHernández-CruzBNavarro-SarabiaFPhysical function and health-related quality of life of Spanish patients with ankylosing spondylitisArthritis Rheum200349448348712910553
   PubMed Web of Science ®Google Scholar
• de las PeñasCFBlancoCAPérezAAPageJCRelationship among mobility, functionality and quality of life in subjects presenting with ankylosing spondylitisFisioterapia2006283143151
   Google Scholar
• Ariza-ArizaRHernández-CruzBLópez-AntequeraGNavarro-SarabiaFVariables related to utility in patients with ankylosing spondylitisClin Rheumatol200928220721118825472
   PubMed Web of Science ®Google Scholar
• O’DwyerTO’SheaFWilsonFDecreased health-related physical fitness in adults with ankylosing spondylitis: a cross-sectional controlled studyPhysiotherapy2016102220220926119877
   PubMed Web of Science ®Google Scholar
• TälliSEtchetoAFautrelBPatient global assessment in psoriatic arthritis: what does it mean? An analysis of 223 patients from the Psoriatic Arthritis Impact of Disease (PsAID) studyJoint Bone Spine201683333534026677994
   PubMed Web of Science ®Google Scholar
• Puyraimond-ZemmourDEtchetoAFautrelBAssociations between five important domains of health and the patient acceptable symptom state in rheumatoid arthritis and psoriatic arthritis: a cross-sectional study of 977 patientsArthritis Care Res (Hoboken)201769101504150927998030
   PubMed Web of Science ®Google Scholar
• BrodszkyVPéntekMBálintPComparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional surveyScand J Rheumatol201039430330920166848
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• López-GonzálezRLeónLLozaERedondoMde YébenesMJCarmonaLAdherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature reviewClin Exp Rheumatol201533455956925602291
   PubMed Web of Science ®Google Scholar
• LyuRGovoniMDingQTreatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in GermanyRheumatol Int201636114315326314368
   PubMed Web of Science ®Google Scholar
• SaadAAAshcroftDMWatsonKDPersistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics RegisterArthritis Res Ther2009112R5219356232
   PubMed Web of Science ®Google Scholar
• KristensenLEKarlssonJAEnglundMPeterssonIFSaxneTGeborekPPresence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish arthritis treatment group registerArthritis Care Res (Hoboken)201062101362136920506310
   PubMed Web of Science ®Google Scholar
• FavalliEGSelmiCBeccioliniAEight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis: a multi-center retrospective analysisArthritis Care Res (Hoboken)201769686787427696735
   PubMed Web of Science ®Google Scholar
• RenziCDi PietroCTabolliSParticipation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritisClin Exp Dermatol201136888588821790723
   PubMed Web of Science ®Google Scholar
• NollaJRodríguezMMartin-MolaEPatients’ and rheumatologists’ preferences for the attributes of biological agents used in the treatment of rheumatic diseases in SpainPatient Prefer Adherence2016101101111327382258
   PubMed Web of Science ®Google Scholar
• RotheryCBojkeLRichardsonGA discrete choice experiment to explore patients’ willingness to risk disease relapse from treatment withdrawal in psoriatic arthritisClin Rheumatol201635122967297427796664
   PubMed Web of Science ®Google Scholar
• SokkaTKautiainenHHannonenPPincusTChanges in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general populationArthritis Rheum200654103113311817009231
   PubMed Web of Science ®Google Scholar
• van EchteldICiezaABoonenAIdentification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and healthJ Rheumatol200633122475248317013999
   PubMed Web of Science ®Google Scholar
• CarterRRiantawanPBanhamSWSturrockRDAn investigation of factors limiting aerobic capacity in patients with ankylosing spondylitisRespir Med1999931070070810581658
   PubMed Web of Science ®Google Scholar
• OzdemyrOInaniciFHasçelikZReduced vital capacity leads to exercise intolerance in patients with ankylosing spondylitisEur J Phys Rehabil Med201147339139721364507
   PubMed Web of Science ®Google Scholar
• HalvorsenSVøllestadNKFongenCPhysical fitness in patients with ankylosing spondylitis: comparison with population controlsPhys Ther201292229830922095208
   PubMed Web of Science ®Google Scholar
• MarcoraSCasanovaFWilliamsEJonesJElamanchiRLemmeyAPreliminary evidence for cachexia in patients with well-established ankylosing spondylitisRheumatology200645111385138816603581
   PubMed Web of Science ®Google Scholar
• ToussirotEMichelFWendlingDBone density, ultrasound measurements and body composition in early ankylosing spondylitisRheumatology (Oxford)200140888288811511757
   PubMed Web of Science ®Google Scholar
• SaadAASymmonsDPMNoycePRAshcroftDMRisks and benefits of tumor necrosis factor-α inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trialsJ Rheumatol200835588389018381787
   PubMed Web of Science ®Google Scholar
• CurkendallSPatelVGleesonMCampbellRSZagariMDuboisRCompliance with biologic therapies for rheumatoid arthritis: so patient out-of-pocket payments matter?Arthritis Rheum200859101519152618821651
   PubMed Web of Science ®Google Scholar
• HarleyCRFrytakJRTandonNTreatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexateAm J Manag Care200396 SupplS136S14314577718
   PubMed Web of Science ®Google Scholar
• BorahBJHuangXZarotskyVGlobeDTrends in RA patients’ adherence to subcutaneous anti-TNF therapies and costsCurr Med Res Opin20092561365137719425902
   PubMed Web of Science ®Google Scholar
• CalipGSAdimadhyamSXingSRinconJCLeeWJAnguianoRHMedication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditionsSemin Arthritis Rheum201747215716428410817
   PubMed Web of Science ®Google Scholar
• LizánLComellasMPazSPovedaJLMeleticheDPolancoCTreatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literaturePatient Prefer Adherence201481653166425525341
   PubMed Web of Science ®Google Scholar
• van den BemtBJZwikkerHEvan den EndeCHMedication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literatureExpert Rev Clin Immunol20128433735122607180
   PubMed Web of Science ®Google Scholar
• KravitzRLMelnikowJEngaging patients in medical decision makingBMJ2001323731358458511557690
   PubMed Web of Science ®Google Scholar
• NotaIDrossaertCHTaalEVonkemanHEvan de LaarMAPatient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional surveyBMC Musculoskelet Disord20141533325281209
   PubMed Web of Science ®Google Scholar